These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9484914)

  • 41. The role of chemotherapy in the curative treatment of head and neck cancer.
    Pfister DG; Shaha AR; Harrison LB
    Surg Oncol Clin N Am; 1997 Oct; 6(4):749-68. PubMed ID: 9309092
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phase I trial of retinoic acid and cis-platinum for advanced squamous cell cancer of the head and neck based on experimental evidence of drug synergism.
    Weisman RA; Christen R; Los G; Jones V; Kerber C; Seagren S; Glassmeyer S; Orloff LA; Wong W; Kirmani S; Howell S
    Otolaryngol Head Neck Surg; 1998 May; 118(5):597-602. PubMed ID: 9591856
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The management of metastatic squamous cell carcinoma in cervical lymph nodes from an unknown primary.
    Medini E; Medini AM; Lee CK; Gapany M; Levitt SH
    Am J Clin Oncol; 1998 Apr; 21(2):121-5. PubMed ID: 9537194
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Planned neck dissection after concomitant radiochemotherapy for advanced head and neck cancer.
    Frank DK; Hu KS; Culliney BE; Persky MS; Nussbaum M; Schantz SP; Malamud SC; Holliday RA; Khorsandi AS; Sessions RB; Harrison LB
    Laryngoscope; 2005 Jun; 115(6):1015-20. PubMed ID: 15933512
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multiagent concurrent chemoradiotherapy for locoregionally advanced squamous cell head and neck cancer: mature results from a single institution.
    Adelstein DJ; Saxton JP; Rybicki LA; Esclamado RM; Wood BG; Strome M; Lavertu P; Lorenz RR; Carroll MA
    J Clin Oncol; 2006 Mar; 24(7):1064-71. PubMed ID: 16505425
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comparison of treatment outcomes by radiochemotherapy and postoperative radiotherapy in locally advanced squamous cell carcinomas of head and neck.
    Fortin A; Caouette R; Wang CS; Vigneault E
    Am J Clin Oncol; 2008 Aug; 31(4):379-83. PubMed ID: 18845998
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Outcome of locally advanced stage III and IV head and neck cancer treated by surgery and postoperative external beam radiotherapy.
    Kumar PP; Good RR; Epstein BE; Yonkers AJ; Ogren FP; Moore GF
    Laryngoscope; 1987 May; 97(5):615-20. PubMed ID: 3573911
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Patterns of failure among patients with squamous cell carcinoma of the head and neck who obtain a complete response to chemoradiotherapy.
    Yovino S; Settle K; Taylor R; Wolf J; Kwok Y; Cullen K; Ord R; Zimrin A; Strome S; Suntharalingam M
    Head Neck; 2010 Jan; 32(1):46-52. PubMed ID: 19484762
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A long-term assessment of adjuvant chemotherapy on outcome of patients with extracapsular spread of cervical metastases from squamous carcinoma of the head and neck.
    Johnson JT; Wagner RL; Myers EN
    Cancer; 1996 Jan; 77(1):181-5. PubMed ID: 8630927
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Management of advanced stage squamous cell carcinoma of the head and neck.
    Forastiere AA
    Am J Med Sci; 1986 Jun; 291(6):405-15. PubMed ID: 3521275
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chemotherapy in the management of squamous-cell carcinoma of the head and neck.
    Lamont EB; Vokes EE
    Lancet Oncol; 2001 May; 2(5):261-9. PubMed ID: 11905780
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of tumor board recommendations on treatment outcome for locally advanced head and neck cancer.
    Nguyen NP; Vos P; Lee H; Borok TL; Karlsson U; Martinez T; Welsh J; Cohen D; Hamilton R; Nguyen N; Nguyen LM; Vinh-Hung V
    Oncology; 2008; 75(3-4):186-91. PubMed ID: 18841033
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Planned neck dissection in the treatment of locally advanced head and neck squamous cell carcinoma].
    Jiang L; Lou JL; Wang KJ; Fang MY; Fu ZF
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Feb; 53(2):92-96. PubMed ID: 29429177
    [No Abstract]   [Full Text] [Related]  

  • 54. [Attempts to improve organ preservation in patients with squamous cell carcinoma of the head and neck].
    Taguchi T; Tsukuda M
    Gan To Kagaku Ryoho; 2005 Dec; 32(13):2030-4. PubMed ID: 16352924
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Induction chemotherapy with docetaxel, cisplatin and fluorouracil followed by surgery and concurrent chemoradiotherapy improves outcome of recurrent advanced head and neck squamous cell carcinoma.
    Yang WC; Chen CH; Tang JY; Wu CF; Liu YC; Sun Y; Lin SF
    Anticancer Res; 2014 Jul; 34(7):3765-73. PubMed ID: 24982400
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Postoperative Radiation Therapy for Metastatic Cervical Adenopathy.
    Garden AS; Reddy JP
    Semin Radiat Oncol; 2019 Apr; 29(2):144-149. PubMed ID: 30827452
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Role of neoadjuvant chemotherapy for management of resectable head and neck cancer].
    Horiuchi M; Tamura Y; Miyake H
    Gan To Kagaku Ryoho; 1994 Mar; 21(4):417-24. PubMed ID: 8129381
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Postoperative concurrent chemoradiotherapy with mitomycin in advanced squamous cell carcinoma of the head and neck: results from three prospective randomized trials.
    Rewari AN; Haffty BG; Wilson LD; Son YH; Joe JK; Ross DA; Papac RJ; Sasaki CT; Fischer JJ
    Cancer J; 2006; 12(2):123-9. PubMed ID: 16630403
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intensive induction chemotherapy and radiation for organ preservation in patients with advanced resectable head and neck carcinoma.
    Urba SG; Forastiere AA; Wolf GT; Esclamado RM; McLaughlin PW; Thornton AF
    J Clin Oncol; 1994 May; 12(5):946-53. PubMed ID: 8164046
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Safety and efficacy of concurrent carboplatin plus radiotherapy for locally advanced head and neck cancer patients ineligible for treatment with cisplatin.
    Hamauchi S; Yokota T; Onozawa Y; Ogawa H; Onoe T; Kamijo T; Iida Y; Nishimura T; Onitsuka T; Yasui H
    Jpn J Clin Oncol; 2015 Dec; 45(12):1116-21. PubMed ID: 26423341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.